Search Results - "A. Segura Huerta"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Toxic epidermal necrolysis associated with interleukin-2 by Segura Huerta, AA, Tordera, P, Cercos, AC, Yuste, AL, Lopez-Tendero, P, Reynes, G

    Published in The Annals of pharmacotherapy (01-07-2002)
    “…BACKGROUND: Metastatic renal cell carcinoma (MRCC) has been characteristically unresponsive to chemotherapy. In lieu of an effective regimen, interleukin-2…”
    Get full text
    Journal Article
  2. 2

    Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables by Ponce Lorenzo, J, Segura Huerta, A, Díaz Beveridge, R, Giménez Ortiz, A, Aparisi Aparisi, F, Fleitas Kanonnikoff, T, Richart Aznar, P, de la Cueva Sapiña, H, Montalar Salcedo, J

    Published in Clinical & translational oncology (01-07-2007)
    “…To identify clinical and biologic variables with significant impact on survival in patients with carcinomas of an unknown primary site (CUP) and to develop a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Advanced urethral carcinoma. Which is the best management of a infrequent disease? by Segura Huerta, A, Molina Saera, J, Palomar Abad, L, Pellín Ariño, L, Guerrero Zotano, A, Calderero Aragón, V

    Published in Actas urologicas españolas (01-01-2004)
    “…Urethral cancer is an uncommon tumor (<0.1% of all genitourinary neoplasms). Most of them are squamous carcinoma, adenocarcinomas are about 5% of all urethral…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Thirteen years' survival in a patient with isolated skin metastases of a gastric carcinoma. What kind of disease is that? by Segura Huerta, A, Pérez-Fidalgo, J A, López-Tendero, P, Gironés Sarrió, R, Aparicio Urtasun, J

    “…Gastric adenocarcinoma is a high-lethality tumour and has a great tendency to recur. Liver and peritoneum are the places where the metastases are most…”
    Get full text
    Journal Article
  12. 12

    Embryonal rhabdomyosarcoma of the prostate. Report of a case and review of the literature by Segura Huerta, A, López Tendero, P, Yuste Izquierdo, A, Gironés Sarrió, R, Pérez Fidalgo, J, Aparicio Urtasun, J

    Published in Actas urologicas españolas (01-02-2001)
    “…The rhabdomyosarcoma (RMS) is a tumour derived from the mesenchymal cells that give origin to striate muscle. It appears most frequently at the pediatric age,…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Lesion cutánea como primera manifestación de un adenocarcinoma gástrico by Iranzo Gómez, E., Segura Huerta, A., Palomar Abad, L., Silla Búrdalo, G., Saro, E.

    Published in Oncología (Barcelona) (01-05-2006)
    “…Las metástasis cutáneas son poco frecuentes y suelen aparecer en estadios finales de los cánceres. Sólo en un 0,8% de las ocasiones son la primera…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Carcinoma uretral con extensión locorregional importante. ¿cómo manejamos una patología infrecuente? by Segura huerta, A., Molina saera, J., Palomar abad, L., Pellín ariño, L., Guerrero zotano, A., Calderero aragón, V.

    Published in Actas urologicas españolas (2004)
    “…El carcinoma primario de uretra es un tumor de escasa incidencia, ocupa menos del 0,1% de las neoplasias genitourinarias. La mayoría de tumores corresponden a…”
    Get full text
    Journal Article
  17. 17

    Association of multiple myeloma and solid neoplasms: analysis of 13 cases by Todolí Parra, J A, Campo López, C, Segura Huerta, A, Alonso Estellés, R, Saro Pérez, E, Torrego Giménez, A, Santaballa Bertrán, A, Pastor Borgoñón, M, Calabuig Alborch, J R

    Published in Revista clínica espanõla (01-11-1999)
    “…The diagnosis of second malignancies in patients with multiple myeloma is uncommon. It is debatable whether this tumor is in itself a risk factor for the…”
    Get more information
    Journal Article
  18. 18

    Supervivencia de trece años en una paciente con metástasis cutáneas aisladas de adenocarcinoma gástrico: ¿Ante qué enfermedad nos encontramos? by Segura Huerta, A., Pérez-Fidalgo, J. A., López-Tendero, P., Gironés Sarrió, R., Aparicio Urtasun, J.

    “…El adenocarcinoma gástrico es un tumor con elevado porcentaje de recaídas y una alta letalidad. Peritoneo e hígado son las localizaciones más frecuentes de las…”
    Get full text
    Journal Article
  19. 19